SCHEMBL6560255

SCHEMBL6560255

Cc1cc(C(C)N)ccc1C(=O)Nc1ccnc2[nH]ncc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 8/20 0.52
ROCK1 Q13464 5/20 0.52
PRKD3 O94806 2/20 0.52
PRKACA P17612 2/20 0.52
PRKCQ Q04759 2/20 0.52
PRKCD Q05655 2/20 0.52
PKN2 Q16513 2/20 0.52
PRKD2 Q9BZL6 2/20 0.52
CIT O14578 1/20 0.52
MAP4K4 O95819 1/20 0.52
PRKCB P05771 1/20 0.52
PRKCA P17252 1/20 0.52
CSNK2A2 P19784 1/20 0.52
MARK3 P27448 1/20 0.52
BMPR1A P36894 1/20 0.52
CSNK1A1 P48729 1/20 0.52
CLK1 P49759 1/20 0.52
GSK3A P49840 1/20 0.52
GSK3B P49841 1/20 0.52
CDK9 P50750 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6559090 0.89 ROCK2 (0.49) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL6559156 0.88 ROCK2 (0.48) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL6559978 0.88 ROCK2 (0.48) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL6559035 0.88 ROCK2 (0.48) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL6559054 0.86 ROCK2 (0.46) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL6559051 0.86 ROCK2 (0.46) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL1554050 0.85 ROCK2 (0.69) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL1552873 0.85 ROCK2 (0.69) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL1553451 0.85 ROCK2 (0.45) ROCK2ROCK1PRKD3PRKACAPRKCQ
SCHEMBL1553452 0.85 ROCK2 (0.45) ROCK2ROCK1PRKD3PRKACAPRKCQ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391454-A1 Substituted benzamide compounds with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2004-02-25 EP disclosed
EP-1195372-A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2002-04-10 EP disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
US-5958944-A TREATMENT OF CIRCULATORY DISEASES IN CORONARY, CEREBRAL, RENAL AND PERIPHERAL ARTERIES, AS A THERAPEUTIC AGENT FOR HYPERTENSION, ANGINA PECTORIS, AND RENAL AND PERIPHERAL CIRCULATION DISORDER, ANTIASTHMATIC AGENT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-09-28 US disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed